Cellectar Biosciences Inc (CLRBW) News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:June 23, 2023...

Securities Registration Statement (s-1/a)

0001376804 true S-1/A

Securities Registration Statement (s-1)

0001376804 false

Information Statement - All Other (definitive) (def 14c)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE...

Proxy Statement - Other Information (preliminary) (pre 14c)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:May 31, 2023...

Post-effective Amendment to Registration Statement (pos Am)

0001376804 true POS AM 0001376804 2023-01-01 2023-03-31 iso4217:USD...

Post-effective Amendment to Registration Statement (pos Am)

0001376804 true POS AM

Quarterly Report (10-q)

0001376804 false 2023 Q1 --12-31